These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 17452862)
1. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer. Iguchi T; Matsuoka J; Sato S; Okumura Y; Omori M; Mifune H; Akaki S; Kanazawa S Clin Nucl Med; 2007 May; 32(5):361-2. PubMed ID: 17452862 [TBL] [Abstract][Full Text] [Related]
2. F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review. Cohen R; Bihan H; des Guetz G; Wind P; Martin A Ann Endocrinol (Paris); 2009 Dec; 70(6):468-72. PubMed ID: 19744643 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270 [TBL] [Abstract][Full Text] [Related]
4. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Lind P; Kohlfürst S Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610 [TBL] [Abstract][Full Text] [Related]
5. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [TBL] [Abstract][Full Text] [Related]
6. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493 [TBL] [Abstract][Full Text] [Related]
7. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT. Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459 [TBL] [Abstract][Full Text] [Related]
8. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies. Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717 [TBL] [Abstract][Full Text] [Related]
9. Thyroid Metastasis From Hepatocellular Carcinoma Visualized by 18F-FDG PET/CT Imaging. Yin H; Luo R; Xiu Y; Hu Y; Shi H Clin Nucl Med; 2018 Dec; 43(12):e455-e457. PubMed ID: 30247212 [TBL] [Abstract][Full Text] [Related]
10. Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT. Piccardo A; Massollo M; Bandelloni R; Arlandini A; Foppiani L Clin Nucl Med; 2015 Aug; 40(8):e417-9. PubMed ID: 26053727 [TBL] [Abstract][Full Text] [Related]
11. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995 [TBL] [Abstract][Full Text] [Related]
12. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Miraldi F; Vesselle H; Faulhaber PF; Adler LP; Leisure GP Clin Nucl Med; 1998 Jan; 23(1):3-7. PubMed ID: 9442955 [TBL] [Abstract][Full Text] [Related]
13. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma. Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan. Jackson RT; Sinha P; Conrad GR Clin Nucl Med; 2008 Jul; 33(7):505-6. PubMed ID: 18580244 [TBL] [Abstract][Full Text] [Related]
15. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190 [TBL] [Abstract][Full Text] [Related]
16. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm? Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT of Seminal Vesicle Metastasis From Ascending Colon Adenocarcinoma. Hsu YL; Lin IC; Tung CL Clin Nucl Med; 2017 Feb; 42(2):138-139. PubMed ID: 28005644 [TBL] [Abstract][Full Text] [Related]
18. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma. Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565 [TBL] [Abstract][Full Text] [Related]
19. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Leboeuf R; Bénard F; Langlois MF Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803 [TBL] [Abstract][Full Text] [Related]
20. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography. Low SC; Sinha AK; Sundram FX Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]